Stone House Investment Management »

Biogen Idec shares owned by Stone House Investment Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Stone House Investment Management from 13F filings

Historical chart of Stone House Investment Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Stone House Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Stone House Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $19k 96 193.84
2024-03-31 $31k 145 215.63

More positions owned by Stone House Investment Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Total Usd (IUSB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Procter & Gamble Company (PG)
Ishares Tr S&p 500 Grwt Etf (IVW)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Blackrock Etf Trust Us Eqt Factor (DYNF)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Eafe Grwth Etf (EFG)
Ishares Tr Core Msci Total (IXUS)
Ishares Tr S&p 500 Val Etf (IVE)
Ishares Tr Mbs Etf (MBB)
Ishares Msci Emrg Chn (EMXC)
Ishares Tr U.s. Tech Etf (IYW)
Ishares Tr Core Us Aggbd Et (AGG)

View all positions for Stone House Investment Management

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Morgan Stanley
Goldman Sachs Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec